The present invention relates to compounds of the formula (I) 1
and pharmaceutically acceptable salts thereof, for use as therapeutically
active substances. The compounds are useful for the treatment and/or
prophylaxis of diseases which are associated with the modulation of CB1
receptors including obesity.
